← All indications
Neoplastic Cells, Circulating
Exfoliate neoplastic cells circulating in the blood and associated with metastasizing tumors.
Drugs by status
Phase 4 trials (6)
Phase 3 trials (4)
Phase 2 trials (12)
Phase 1 trials (2)
Other trials (3)
Organizations
Organization Involved with Phase 4 Indications (15)
- Ipsen
- Palacky University
- The Institute of Molecular and Translational Medicine, Czech Republic
- Triemli Hospital
- University of Zurich
- Fudan University
- The University of Hong Kong
- University of Ostrava
- Cantonal Hospital of St. Gallen
- Charles University
- Tomas Bata Hospital Zlin
- Johnson and Johnson
- Hospital Novy Jicin
- Hong Kong Children's Hospital
- Cantonal Hospital Winterthur
Organization Involved with Phase 3 Indications (2)
Organization Involved with Phase 2 Indications (26)
- Amgen
- Roche
- Merck
- Sanofi
- GlaxoSmithKline
- National Cancer Institute (NCI)
- National Cancer Institute, France
- Duke University
- Institut Bergonié
- Northwestern University
- Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
- UNICANCER
- Zhejiang University
- Free University of Amsterdam
- Netherlands Cancer Institute
- University of Montpellier
- Curie Institute
- European Organisation for Research and Treatment of Cancer
- Janssen Pharmaceutica NV
- University of Texas at Houston
- Free University of Brussels
- Erasmus University Rotterdam
- Dutch Cancer Society
- National Comprehensive Cancer Network
- University of Stavanger
- People's Liberation Army of China
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (1)